U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160946) titled 'Risk Assessment for HBV-Related Liver Cancer' on Aug. 02.
Brief Summary: Liver cancer is a severe disease worldwide. The incidence and mortality rates of liver cancer in China is the highest in the world. This project aims to perform a prospective, multi-center, large sample cohort study for HBV related high-risk individuals. Based on multimodal data fusion and AI technique, stratified management and follow-up system are conducted for HBV-related high-risk populations of liver cancer, in order to improve the early diagnosis rate of liver cancer.
Study Start Date: May 10
Study Type: OBSERVATIONAL
Condition:
HBV-related Liver Cirr...